Core Concepts
War-torn Ukraine faces challenges in combating Hepatitis C amidst conflict.
Abstract
Standalone Note here
The content highlights the struggles faced by Ukraine in managing Hepatitis C infections amidst the ongoing war. Key points include:
- Maksym's battle and victory against HCV in a war-torn region.
- Ukraine's high prevalence of HCV, primarily due to injection drug use.
- Challenges faced in providing care to HCV patients, especially after the Russian invasion.
- Impact on healthcare facilities and patients during the war.
- Efforts by organizations like the Alliance for Public Health (APH) to provide HCV treatment.
- Mobile Treatment Points repurposed to deliver healthcare in de-occupied territories.
- #HelpNow initiative to assist displaced individuals with healthcare needs.
- Plans for long-term healthcare rebuilding post-conflict.
Stats
Ukraine's HCV prevalence estimated at 3.1% in 2020.
230 HCV treatment centers treating 16,000-18,000 patients annually.
APH program enrollment dropped to 2041 patients post-invasion.
APH provided approximately 25,000 HCV rapid diagnostic tests since the war began.
Retention rate of 98% and treatment effectiveness of 97% during the war, according to APH.
Quotes
"It doesn't matter if they kill me, but it's better to die healthy." - Maksym
"People were desperate. Running away from the immediate danger of war and seeking safety was prioritized over their health." - Lyudmyla
"It's dangerous but is rewarding too to know that we have brought help to these people." - Anna Korobchuk